Studies have shown that active fund managers routinely underperform the S&P500 index*​

vTv Therapeutics Inc. (NASDAQ: VTVT)

VTVT Stock Predictions and Ratings

WSX Rating:
STRONG SELL
WSX Forecast (1yr):
-90.20%
Analyst Rating:
STRONG BUY
Analyst Forecast (1yr):
54.70%

VTVT Stock Analysis

VTVT PE Ratio:

VTVT PEG Ratio: Not Available

VTVT Forward EPS Growth (12 month): 0.00%

VTVT PS Ratio: 2.3

VTVT PSG Ratio:

VTVT Forward Revenue Growth (12 month): -88.00%

VTVT Articles

No data was found